The recent rapid progression of drug development, diagnostic tests, and healthcare tools have pushed us into new territory that was unthinkable – or even unknown – just a decade ago. While sectors beg for bailouts, biopharma has remained buoyant and resilient in the face of COVID-19.
Biopharma and Tech Innovators – Summer 2020
Download Xconomy and EBD Group’s new special report Biopharma and Tech Innovators – Summer 2020 to learn more about the cutting-edge companies behind these innovations that are disrupting the sector and revolutionizing the healthcare landscape.
What’s inside:
- Company profiles with insider info about their latest advancements
- How to secure biotech deals
- Special sections on drug discovery and development, immunology and oncology, emerging therapies and startups
